The Need: The poultry industry faces significant challenges due to infectious bursal disease (IBD), a highly contagious and economically impactful viral infection affecting young chickens. Existing vaccines, while effective, are costly and time-consuming to produce, primarily relying on inactivated IBDV antigens derived from young chicks, posing logistical and ethical concerns. A pressing need exists for accessible, efficient, and sustainable vaccine solutions to combat IBD and safeguard poultry health and production.

The Technology: Our innovative technology revolutionizes IBD vaccine production by harnessing advanced molecular techniques targeting the hypervariable region of VP2, a crucial viral protein eliciting protective immune responses. By leveraging this approach, we engineer highly effective vaccines with enhanced antigenic specificity and potency. Our platform optimizes antigen production in scalable systems, such as eggs or cell cultures, ensuring consistent quality and yield while circumventing the limitations of traditional methods. Furthermore, our technology facilitates rapid vaccine development, enabling timely responses to emerging IBDV strains and minimizing production costs.

Commercial Applications:

• Production of next-generation IBD vaccines for poultry farms and hatcheries.
• Integration into existing vaccine manufacturing processes for enhanced efficacy and cost-effectiveness.
• Deployment in global poultry markets to mitigate the impact of IBD outbreaks and improve industry sustainability.

Benefits/Advantages:

• Enhanced vaccine efficacy through precise targeting of VP2 antigenic sites, bolstering immune responses and disease protection.
• Cost-effective production in scalable systems such as eggs or cell cultures, reducing manufacturing expenses and enhancing accessibility.
• Accelerated vaccine development and deployment, enabling rapid responses to evolving IBDV strains and market demands.
• Ethical and logistical advantages by eliminating reliance on young chick-derived antigens, addressing animal welfare concerns and streamlining production workflows.
• Improved poultry health and productivity, minimizing losses associated with IBD outbreaks and ensuring sustainable meat and egg production.